Multicentric recurrence of intraductal papillary neoplasms of bile duct in the remnant intrahepatic bile duct after curative resection  by Narita, Masato et al.
CASE REPORT – OPEN ACCESS
International Journal of Surgery Case Reports 12 (2015) 123–127
Contents lists available at ScienceDirect
International Journal of Surgery Case Reports
journa l homepage: www.caserepor ts .com
Multicentric recurrence of intraductal papillary neoplasms of bile
duct in the remnant intrahepatic bile duct after curative resection
Masato Naritaa,∗, Bunji Endob, Yoshinori Mizumotob, Ryo Matsusuea, Hiroaki Hataa,
Takashi Yamaguchia, Tetsushi Otania, Iwao Ikaia
a Department of Surgery, National Hospital Organization, Kyoto Medical Center, 1-1 Mukaihata-cho, Fukakusa, Fushimi-ku, Kyoto 612-8555, Japan
b Gastroenterology, National Hospital Organization, Kyoto Medical Center, 1-1 Mukaihata-cho, Fukakusa, Fushimi-ku, Kyoto 612-8555, Japan
a r t i c l e i n f o
Article history:
Received 1 May 2015
Received in revised form 27 May 2015
Accepted 28 May 2015
Available online 30 May 2015
Keywords:
IPNB
Double balloon enteroscopy
Liver
Cholangiocarcinoma
Hepaticojejunostomy
Prognosis
a b s t r a c t
INTRODUCTION: There have been few reports on the prognosis of patients with intraductal papillary
neoplasms of the bile duct (IPNB). Here we report a case of IPNB in a patient with early-stage carcinoma
who had multicentric recurrence in the remnant hepatic bile duct after curative resection.
CASE PRESENTATION: A 78-year-old man with hepatic dysfunction and cholestasis was referred to our
hospital. Preoperative imaging studies revealed the presence of papillary tumors in the left hepatic duct
and common hepatic duct, while no tumor lesions were detected in the right hepatic duct. This patient
underwent left hepatectomy, extra-hepatic bile duct resection with biliary reconstruction, and regional
lymphnode dissection. On the basis of pathological examination, this patient was diagnosed with mul-
tiple IPNB with early-stage adenocarcinoma with negative surgical margin. Postoperative work-up was
periodicallyperformed, indicatingnoevidenceof recurrence,while thepatienthad sustainedhepatic dys-
function, cholestasis, and repetitive cholangitis since the early postoperative period. Finally, recurrence in
the remnant intrahepatic bile duct of the posterior segment was revealed by double balloon enteroscopy
at 29 months after surgery. At 34 months after surgery, internal drainage stents were replaced in both
endoscopic and percutaneous manners within the relapsed intrahepatic bile ducts to address repetitive
cholangitis. These procedures enabled the patient to remain asymptomatic until death at 41months after
surgery.
DISCUSSION: Multicentric recurrence in the remnant intrahepatic bile duct after surgery may occur in
IPNB patients with multiple lesions. An endoscopic approach may be useful in such cases, not only in the
diagnosis of remnant intrahepatic bile duct recurrence but also for palliation of symptoms.
© 2015 The Authors. Published by Elsevier Ltd. on behalf of Surgical Associates Ltd. This is an open
access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
1. Introduction
Intraductal papillaryneoplasmof thebile duct (IPNB) is a newly-
recognized disease and is categorized as a subtype of biliary cystic
tumor in the World Health Organization classiﬁcation of 2010 [1].
IPNB is deﬁned as a biliary epithelial tumor with exophytic nature,
exhibiting a papillary mass within the bile duct lumen and with a
prominent intraductal growth pattern. It has been identiﬁed as the
biliary counterpart of intraductal papillary mucinous neoplasm of
the pancreas (IPMN) [2]. Despite a growing number of publications
on IPNB, its long-term prognosis and pattern of recurrence remain
poorly understood.
Here we report a case of relapsed IPNB with suspected
metachronous multicentric recurrence in the remnant hepatic bile
duct at 29 months after curative resection. The clinical course of
∗ Corresponding author. Tel.: +81 756419161.
E-mail address: narinari@kuhp.kyoto-u.ac.jp (M. Narita).
the patient was reviewed, and the prognosis of IPNBwas discussed
in the context of relevant literature.
2. Case presentation
A 78-year-old man was referred to our hospital for evalua-
tion of right upper quadrant pain persisting for 2 days. Laboratory
examination revealed cholestasis [total bilirubin, 3.9mg/dL; alka-
line phosphatase (ALP), 986 IU/L; gamma-glutamyltranspeptidase
(-GTP), 587 IU/L] and hepatic dysfunction [aspartate aminotrans-
ferase (AST), 603U/L; alanine aminotransferase (ALT), 414U/L].
Contrast-enhanced computed tomography (CE-CT) showed dilata-
tion of the intrahepatic bile duct in the left hemiliver and the
extrahepatic bile ducts and a mass lesion in the left hepatic duct
(Fig. 1A). Endoscopic retrograde cholangiography (ERC) revealed
the presence of multiple blood clots at the ampulla of Vater
and ﬁlling defects within the left hepatic duct (Fig. 1B). Peroral
cholangioscopy (POCS) revealed papillary tumors without mucin
production at the oriﬁce of the left hepatic duct, while no tumor
http://dx.doi.org/10.1016/j.ijscr.2015.05.033
2210-2612/© 2015 The Authors. Published by Elsevier Ltd. on behalf of Surgical Associates Ltd. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Fig. 1. Preoperative imaging studies: (A) Contrast-enhanced computed tomography (CE-CT): Arrowheads showsolid lesions in the left hepatic duct. (B) Endoscopic retrograde
cholangiography (ERC): Arrowheads indicate ﬁlling defects in the left hepatic duct. (C–D) Peroral cholangioscopy: (C) Arrowheads indicate the oriﬁce of the right hepatic
duct. No tumor lesions are presented. Arrows indicate the oriﬁce of the left hepatic duct which is completely ﬁlled with papillary tumors. (D) Arrowheads indicate papillary
tumors located in the common hepatic duct.
lesions were observed right hepatic duct (RHD; Fig. 1C). A papil-
lary tumor was also detected in the common hepatic duct (CHD),
which was located separately from the tumors in the left hepatic
duct (Fig. 1D). Both papillary tumors were biopsied, and patholog-
ical examination of biopsy specimens revealed well-differentiated
adenocarcinoma of the bile duct. Moreover, negative biopsies were
performed from the biliary epithelium at the hilar and RHD;
on pathological examination, normal biliary epithelium was con-
ﬁrmed in these biopsy specimens. Based on these examinations,
the patient was diagnosed with left side-dominated intraductal
growth-type cholangiocarcinoma. There was no evidence of dis-
tant metastases. We planned a surgical intervention with curative
intent.
Thepatientunderwent left hepatectomywith left-sided caudate
lobectomy, extra-hepatic bile duct resection with biliary recon-
struction, and regional lymphnode dissection. Stumps of bile duct
(RHD and CHD) were negative for cancer by frozen section exami-
nation during surgery. The duration of the operation was 544min,
with blood loss amounting to 600g without blood transfusion. By
gross appearance, two papillary tumors were observed in the left
main hepatic duct and CHD in a discontinuous manner (Fig. 2A).
Microscopically, these tumorswere diagnosed as pancreatobiliary-
type adenocarcinoma (Fig. 2B). Tumor invasion was limited to the
mucosal layer, and lymphatic-vascular involvement was not evi-
dent. There was no lymphnode metastasis (0/19), and the surgical
margin was negative. The patient was diagnosed with multiple
IPNB with early-stage adenocarcinoma. The postoperative course
was uneventful, and the patient was discharged 27 days after
surgery.
After surgery, 8-weekly assessments of blood tests and 6-
monthly abdominal CE-CT scans were performed. No recurrence
was documented until 24 months after surgery; however, biliary
enzymes, includingALP and-GTP, had been substantially elevated
since 5 months after surgery. The patient sustained mild cholan-
gitis twice during this period, which was cured within 2 days by
intravenous antibiotics. At 29 months after surgery, the patient
was admitted to our hospital with fever due to cholangitis. Upon
CT imaging, an anastomotic stenosis of the hepaticojejunostomy
was suspected (Fig. 3A). Double-balloon enteroscopy (DBE) was
performed, revealing papillary tumors protruding from the anas-
tomotic oriﬁce of the hepaticojejunostomy (Fig. 3B). DBE-assisted
ERC showed ﬁlling defects throughout the posterior branch of the
hepatic duct (Fig. 3C and D). Pathological examination of biopsy
specimens revealedwell-differentiated pancreatobiliary-type ade-
nocarcinoma. This result conﬁrmed that cholangitis occurred
because of relapsed IPNB in the intrahepatic bile ducts of the
posterior segment. After discharge, the patient suffered repetitive
cholangitis, forcing him to be admitted to the hospital each time. At
34 months after surgery, plastic stents were endoscopically placed
within the hepatic duct of segment 6 (B6) and segment 7 (B7) in an
attempt to improve chronic cholestasis. CE-CT was performed fol-
lowing this procedure and revealed insufﬁcient drainage of B6. An
additional internal drainage tube was percutaneously placed into
B6 across the anastomosis. These procedures improved the general
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Fig. 2. (A) Gross appearance of resected specimens: *, †, and § correspond to liver parenchyma of segment 2+3, liver parenchyma of segment 4, and common bile duct,
respectively. The photograph enclosed by the solid line indicates magniﬁcation of the area enclosed by the dotted line. (B) Tumor microscopy image indicating the presence
of pancreatobiliary-type adenocarcinoma.
condition of the patient, who remained asymptomatic until death
at 41 months after surgery.
3. Discussion
Owing to the novelty of its disease concept, there have been
few reports on the prognosis of patients with IPNB. Jung et al.
reported on the prognosis of 93 patients with IPNB undergoing
surgery according to the arbitrary-deﬁned classiﬁcation [3]. In
the study, twenty-six patients had mucosa-conﬁned cholangio-
carcinoma, and the 5-year-survival and disease-free-rate of these
patients was approximately 90% and 85%, respectively, while the
prognosis of patients undergoing R0 resectionwas unclear because
9/26 patients underwent surgery with R1 resection. Kim et al.
reported on the long-term outcome of 97 patients with IPNB who
underwent surgery [4]. Of 90 patients undergoing R0 resection,
22 (24.4%) developed tumor recurrence following surgery. Among
them, 17 (77.8 %) developed local tumor recurrence despite R0
resection,while therewas nodescription of the details of preopera-
tive assessment and diagnosis of recurrence. In this context, which
patients had local or remnant intrahepatic bile duct recurrence
remains unclear.
In the present case, preoperative assessment of the entire biliary
tract was rigorously performed using ERC and POCS, and absence
of tumor lesions within the hepatic duct of the future remnant
liver was conﬁrmed. Furthermore, a negative resection margin
was conﬁrmed by frozen section during surgery, and the present
case underwent R0 resection. Pathological examination revealed
mucosa-conﬁned cholangiocarcinoma and multiple lesions at the
common hepatic duct. Therefore, this suggests that IPNB with
multiple lesions may have a possibility of leading to multicentric
recurrence in the remnant intrahepatic bile duct. If so, surgical
resection may not be sufﬁcient in IPNB patients with multiple
lesions, although R0 resection is achieved. How these patients
should be treated remains to be answered. Liver transplantation
for patients with intrahepatic cholangiocarcinoma (ICC) is con-
sidered to be contraindicated in most transplant centers because
data from larger cohort studies conﬁrmed poor post-transplant
outcomes in patients with ICC [5–7]. However, recent data show
excellent outcomes in selected patients, such as patients with soli-
tary ICCs ≤2.0 cm and no lymph node metastasis [8,9]. IPNB is a
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Fig. 3. (A) Postoperative CE-CT imaging study: Arrowheads indicate dilatation of the intrahepatic duct of the posterior segment. (B–D) Postoperative imaging studies using
double-balloon enteroscopy (DBE): (B) Arrowheads and arrow indicate the papillary tumors protruding from the anastomotic oriﬁce of hepatic duct of segment 6 (B6) and
segment 7 (B7), respectively. DBE-assisted direct cholangiography indicates ﬁlling defects throughout B6 (C) and B7 (D).
much less aggravating tumor compared with ICC, and it may be
relevant to consider liver transplantation for IPNB patients with
multiple lesions.
In the present case, we experienced the diagnostic and ther-
apeutic difﬁculties of remnant intrahepatic bile duct recurrence
following major hepatectomy with biliary reconstruction. Postop-
erative work-up was periodically performed, including blood tests
and abdominal CE-CT, with recurrence being recognized by DBE
at 29 months after surgery. This patient had sustained repetitive
cholangitis with increased biliary enzymes since the early post-
operative period. These phenomena may indicate the presence of
recurrence in the remnant intrahepatic bile duct at the early phase
following surgery. Although CE-CT showed dilatation of the intra-
hepatic bile duct, it was difﬁcult to detect recurrent tumor tissue
in the remnant hepatic duct. Hence, periodical CT imaging may be
insufﬁcient in the present case. Recent technical advances in endo-
scopic interventions enable diagnostic and therapeutic ERC even
in patients with altered gastrointestinal anatomies due to surgery
[10]. Therefore in such cases, the use of DBE-assisted direct cholan-
giography should be considered at the early postoperative phase.
This procedure not only allowed diagnosis of recurrence but con-
tributed to improvement of the quality of life of this patient.
In conclusion, we experienced an IPNB case that would have
been expected to have long-term survival because this was a case
of early-stage adenocarcinoma with R0 resection. However, this
case experienced relapse in the remnant intrahepatic bile duct
approximately 2 years after surgery. This suggests that we should
consider multicentric remnant intrahepatic bile duct recurrence in
IPNB patients with multiple lesions. Endoscopic approaches, such
as DBE, may be useful in diagnosis of recurrence and palliation of
symptoms in selected patients.
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